About Notrox Research Private Limited
Data last updated:
Notrox Research Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 23 May 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2014PTC074596. Its GSTIN is 29AAECN6671P1ZL (Karnataka).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹50 Lakh. It is led by directors Bangalore Prakash Shanthala and Hanumanthappa Basavahanalli Anil Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.18 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹99.52 Lakh (net margin 12.2%) and EBITDA of ₹1.65 Cr (EBITDA margin 20.2%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 4% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Notrox Research.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website notroxresearch.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address2nd Floor Survey No.19/3 Bikasipura Road Off Kanakapura Road (Behind Metro Cash &, Carry), Bangalore, Karnataka, India – 560062
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Notrox Research Private Limited
The main business activity of Notrox Research is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Notrox Research Private Limited FY 2025 filings available
Notrox Research Private Limited reported revenue of ₹8.18 Cr (down 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Notrox Research Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 15% fall in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Notrox Research Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.65 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹99.52 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Notrox Research Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 12.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Notrox Research are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Notrox Research Private Limited
Notrox Research Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dornier Medtech India Private Limited | ₹8.85 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Bangalore South, Karnataka, India |
| Cologenesis Healthcare Private Limited | ₹8.78 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Salem, Tamil Nadu, India |
| Indivirtus Healthcare Services Private Limited | ₹8.76 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Chandigarh, India |
| Chemiasoft Private Limited | ₹8.4 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Khairatabad, Telangana, India |
| Sensan Biosciences Private Limited | ₹8.28 Cr (FY 2025) | •••• | •••• | 149.0% | •••• | Chennai City Corporation, Tamil Nadu, India |
| Notrox Research Private Limited this company | ₹8.18 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Bangalore, Karnataka, India |
| Let's Evolve Life Private Limited | ₹8.12 Cr (FY 2024) | •••• | •••• | -25.0% | •••• | Mumbai, Maharashtra, India |
| Convallaer Pharmaceuticals Private Limited | ₹8.1 Cr (FY 2024) | •••• | •••• | 36.0% | •••• | Kanpur, Uttar Pradesh, India |
| Infinia Sciences Private Limited | ₹8.07 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Pune, Maharashtra, India |
| Quench Life Sciences Private Limited | ₹7.8 Cr (FY 2025) | •••• | •••• | 351.0% | •••• | Tirumalagiri, Telangana, India |
| Sphaera Pharma Private Limited | ₹7.73 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Notrox Research by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Notrox Research Private Limited
Notrox Research Private Limited is audited by S V K H & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S V K H & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Notrox Research Private Limited
Notrox Research has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bangalore Prakash Shanthala | Director | 23 May 2014 | 12 Years 4 Months | Current |
| Hanumanthappa Basavahanalli Anil Kumar | Director | 23 May 2014 | 12 Years 4 Months | Current |
Ownership and Shareholding of Notrox Research Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Notrox Research Private Limited
Notrox Research Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Notrox Research Private Limited
Notrox Research operates one associated brand: Notrox Research. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Conducts clinical trials and bioanalytical studies for pharmaceutical industries worldwide. | notroxresearch.com |
Employees and EPFO Compliance at Notrox Research Private Limited
Notrox Research Private Limited has a workforce of 30 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Notrox Research Private Limited
Notrox Research Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Bangalore Prakash Shanthala was appointed as Director on 23 May 2014.
Credit Ratings, Litigation & Regulatory Alerts for Notrox Research Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Notrox Research Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Notrox Research Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Notrox Research Private Limited
Notrox Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECN6671P1ZL | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Notrox Research Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Notrox Research Private Limited
Notrox Research is an active private limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 23 May 2014 (12+ years old) and is registered under CIN U73100KA2014PTC074596.
Notrox Research reported revenue of ₹8.18 Cr for FY 2024 (down 15% YoY).
Notrox Research has 2 current directors:
- Bangalore Prakash Shanthala - Director
- Hanumanthappa Basavahanalli Anil Kumar - Director
Notrox Research reported a net profit of ₹99.52 Lakh (net margin 12.2%) and EBITDA of ₹1.65 Cr (EBITDA margin 20.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Notrox Research is -7% over three years and -4% over five years. In the latest year (FY 2024) revenue fell 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Notrox Research is 29AAECN6671P1ZL, registered in Karnataka.
The CIN (Corporate Identification Number) of Notrox Research is U73100KA2014PTC074596. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Notrox Research was incorporated on 23 May 2014, making it 12+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Notrox Research by revenue are Dornier Medtech India Private Limited, Cologenesis Healthcare Private Limited, Indivirtus Healthcare Services Private Limited, Chemiasoft Private Limited, Sensan Biosciences Private Limited and 5 more, all in the Pharma industry (Contract Research).
Bangalore Prakash Shanthala was appointed as Director on 23 May 2014. Hanumanthappa Basavahanalli Anil Kumar was appointed as Director on 23 May 2014.
Notrox Research can be reached through the website notroxresearch.com. Its registered office is in Bangalore, Karnataka, India.